Cargando…

Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis()

INTRODUCTION: Patients with CF experience pulmonary exacerbations. These are often initially empirically treated with intravenous antibiotics, with antibiotic choice refined after susceptibility testing. METHODS: We completed a 5-year retrospective review of children attending the Paediatric CF Unit...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurley, M.N., Ariff, A.H. Amin, Bertenshaw, C., Bhatt, J., Smyth, A.R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382712/
https://www.ncbi.nlm.nih.gov/pubmed/22436723
http://dx.doi.org/10.1016/j.jcf.2012.02.006
_version_ 1782236531482689536
author Hurley, M.N.
Ariff, A.H. Amin
Bertenshaw, C.
Bhatt, J.
Smyth, A.R.
author_facet Hurley, M.N.
Ariff, A.H. Amin
Bertenshaw, C.
Bhatt, J.
Smyth, A.R.
author_sort Hurley, M.N.
collection PubMed
description INTRODUCTION: Patients with CF experience pulmonary exacerbations. These are often initially empirically treated with intravenous antibiotics, with antibiotic choice refined after susceptibility testing. METHODS: We completed a 5-year retrospective review of children attending the Paediatric CF Unit, Nottingham. The respiratory sampling, antibiotic prescribing and susceptibility testing guidance were audited. Episodes were classified according to the concordance between the antibiotics prescribed and antibiotic susceptibility testing. RESULTS: Of 52 patients who had previously isolated Pseudomonas aeruginosa, 103 antibiotic courses were commenced that coincided with an isolation of P. aeruginosa. P. aeruginosa was fully susceptible, partially susceptible or fully resistant on 33%, 44.7% or 16.5% of occasions respectively. The antibiotic prescriptions were never changed following antibiotic susceptibility testing. We found no association between change in FEV(1) (p = 0.54), change in BMI (p = 0.12) or time to next exacerbation (p = 0.66) and concordance between antibiotic susceptibility and the antibiotics administered. CONCLUSION: This study contributes to mounting evidence questioning the utility of routine antibiotic susceptibility testing.
format Online
Article
Text
id pubmed-3382712
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-33827122012-07-05 Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis() Hurley, M.N. Ariff, A.H. Amin Bertenshaw, C. Bhatt, J. Smyth, A.R. J Cyst Fibros Original Article INTRODUCTION: Patients with CF experience pulmonary exacerbations. These are often initially empirically treated with intravenous antibiotics, with antibiotic choice refined after susceptibility testing. METHODS: We completed a 5-year retrospective review of children attending the Paediatric CF Unit, Nottingham. The respiratory sampling, antibiotic prescribing and susceptibility testing guidance were audited. Episodes were classified according to the concordance between the antibiotics prescribed and antibiotic susceptibility testing. RESULTS: Of 52 patients who had previously isolated Pseudomonas aeruginosa, 103 antibiotic courses were commenced that coincided with an isolation of P. aeruginosa. P. aeruginosa was fully susceptible, partially susceptible or fully resistant on 33%, 44.7% or 16.5% of occasions respectively. The antibiotic prescriptions were never changed following antibiotic susceptibility testing. We found no association between change in FEV(1) (p = 0.54), change in BMI (p = 0.12) or time to next exacerbation (p = 0.66) and concordance between antibiotic susceptibility and the antibiotics administered. CONCLUSION: This study contributes to mounting evidence questioning the utility of routine antibiotic susceptibility testing. Elsevier 2012-07 /pmc/articles/PMC3382712/ /pubmed/22436723 http://dx.doi.org/10.1016/j.jcf.2012.02.006 Text en © 2012 Elsevier B.V. https://creativecommons.org/licenses/by/4.0/ Open Access under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/) license
spellingShingle Original Article
Hurley, M.N.
Ariff, A.H. Amin
Bertenshaw, C.
Bhatt, J.
Smyth, A.R.
Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis()
title Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis()
title_full Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis()
title_fullStr Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis()
title_full_unstemmed Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis()
title_short Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis()
title_sort results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis()
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382712/
https://www.ncbi.nlm.nih.gov/pubmed/22436723
http://dx.doi.org/10.1016/j.jcf.2012.02.006
work_keys_str_mv AT hurleymn resultsofantibioticsusceptibilitytestingdonotinfluenceclinicaloutcomeinchildrenwithcysticfibrosis
AT ariffahamin resultsofantibioticsusceptibilitytestingdonotinfluenceclinicaloutcomeinchildrenwithcysticfibrosis
AT bertenshawc resultsofantibioticsusceptibilitytestingdonotinfluenceclinicaloutcomeinchildrenwithcysticfibrosis
AT bhattj resultsofantibioticsusceptibilitytestingdonotinfluenceclinicaloutcomeinchildrenwithcysticfibrosis
AT smythar resultsofantibioticsusceptibilitytestingdonotinfluenceclinicaloutcomeinchildrenwithcysticfibrosis